Excited to unveil 2048 Ventures 🧬 🤖 ⚙️ Thesis Series. Here is our first post written by Sandra Pérez Baos and focused on the future of Molecular Diagnostics. If you're building in this space, we want to hear from you! 2048.vc/blog/molecular…

Seeing awesome biotech deals? Apply to be a 2048 Ventures 🧬 🤖 ⚙️ Biotech Network Partner! 🔎🧬 We are looking for angels, founders, students and anyone else who sees biotech pre-seed and seed deal flow in Boston, San Francisco and the UK. Details on the role 👇 ⛳️Flagging Deals: When you

🎉 Thank you Julie Wolf for your feature of #Hurdle in "Our Thesis on Molecular Diagnostics"! The future of diagnostics depends on the infrastructure it's built on! 🌍 #HealthTech #Innovation hubs.li/Q028NWQj0

In a major milestone for science, for medicine, and for patients, the world’s first CRISPR drug has been approved in the UK. “A new treatment for sickle-cell disease and transfusion-dependent β-thalassemia has been authorised by the Medicines and Healthcare products Regulatory

My absolute favorite deal this Cyber Monday! Get discount on Kanary - the best way to protect unwanted information exposure online. Full disclosure, I am the lucky first check investor. Use this referral code => kanary_friend_e22b82s x.com/hellokanary/st…

In the new #GrowEverythingPodcast, we explore the dynamic intersection of biotech and venture capital with guest Julie Wolf of 2048 Ventures 🧬 🤖 ⚙️. From microbiologist to VC, Julie sheds light on #biotech investments, #syntheticbiology, and #AI's transformative role. Don't miss it!

🎧 Queued up on the 2048 Ventures 🧬 🤖 ⚙️ playlist: 🎙️ The Hype Happy Hour: Interview with Kevin Flyangolts, h/t Michael F. Schein. Give it a listen👇 shows.acast.com/the-hype-happy…

🗞️2048 Ventures 🧬 🤖 ⚙️ Infographic 2022 Year in Review 📷📷🧵🧵 2048.vc/blog/2023-year…

Our Thesis on Biobanking | ⁦2048 Ventures 🧬 🤖 ⚙️⁩ ⁦Sandra Pérez Baos⁩ ⁦Daniella Cohen⁩ ⁦Julie Wolf⁩ If you are a founder working in the biobanking space we would love to hear from you! 2048.vc/blog/our-thesi…

Excited to share our latest 2048 Ventures thesis series. Here you will find our Thesis on Biobanking. If you are a founder in this space, please reach out! This post is written by Sandra Pérez Baos with significant input from Daniella Cohen and originally appeared on the 2048

We are thrilled to announce our latest investment in Neobe Therapeutics! Read more about why we invested 👇 2048.vc/blog/our-inves… 💡 Neobe is developing a synthetic biology platform to engineer bacteria that disrupt the extracellular matrix (ECM) of solid tumors and enhance

🩺 Applications are open for the 2048 Ventures 🧬 🤖 ⚙️ Digital Health Studio! Apply by March 20th. Are you building the next great 💊 digital health company? The 2048 Ventures 🧬 🤖 ⚙️ Digital Health Studio offers an environment specifically geared towards digital health startups that traditionally don’t

🗞️ 2048 Ventures Portfolio Company News: Neobe Therapeutics raises $2.34m to advance fight against cancer businessweekly.co.uk/posts/neobe-th… 2048 Ventures 🧬 🤖 ⚙️ // #startups // #VC

🗣️ Attention: Digital Health Founders! Are you building a DAY ZERO startup? Apply by March 20th for the opportunity to participate in 2048 Ventures 🧬 🤖 ⚙️ Digital Health Studio. Apply here: 2048.vc/apply_health_s… We offer $250K 💰 for earliest-stage startup teams ready to roll up their

Excited to share 2048 Ventures 🧬 🤖 ⚙️ thesis on the AI opportunities we are looking to invest in. Broadly, we are looking to invest in: 1. Data capture through existing workflows 2. Reinvention of existing workflows through AI Read the full post to see how we unpack this and learn how our

Due TOMORROW! Apply to the 2048 Ventures Biotech and Digital Health Studio by the Spring 2024 deadline. What do we offer? ✅ Personalized 1-1 mentorship from industry experts and our founders. ✅ An extended 256-day program to ensure your success. ✅ Tailored support for

Excited to share our latest 2048 Ventures 🧬 🤖 ⚙️ thesis series. Here you will find our Thesis on Chronic Care Management. If you are a founder in this space, please reach out! This post is written by Daniella Cohen with significant input from Julie Wolf and originally appeared on the